US 9169238
Solid pharmaceutical composition
granted A61PA61P43/00A61P7/10
Quick answer
US patent 9169238 (Solid pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P43/00, A61P7/10, A61P9/00, A61P9/02